John Gordan

Dr. John Gordan, a leading expert from UCSF, shares insights on the latest ASCO guidelines for systemic therapy in advanced hepatocellular carcinoma. He details updated recommendations for first-, second-, and third-line treatments, emphasizing personalized care and team communication. The discussion also addresses treatment options for patients with liver function impairment and highlights the impact of clinical trial evidence on future therapies. Gordan explores the potential of combining local and systemic approaches to enhance patient outcomes.